Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Lidocaine Transdermal Patch Market Is Expected to Grow At A CAGR of 3.2% from 2020 to 2027

Lidocaine is categorized as a local anesthetic which acts by blocking the voltage-gated sodium channel in the central nervous system. The rising prevalence of neuropathic pain and technological advancement in the transdermal drug delivery system will together drive the market growth.

Post-herpetic neuralgia is dominating the clinical application segment in the lidocaine transdermal patch market. The growing incidence of Herpes zoster viral infection due to unsafe sex practices is responsible for the disease etiology of post-herpetic neuralgia. It is also known as shingles infection, which recurs due to reactivation of the varicella-zoster viral infection. The early symptoms associate with the shingles infection is the development of cold sores in the genitalia region which is severely painful, burning sensation, and highly sensitive to touch. The joint pain will be projecting exemplary market growth on account of the growing popularity of sports and athletic activities often resulting in acute joint injuries. Additionally, increasing the geriatric population suffering from osteoporosis causing arthritis will further accentuate the market growth.

Browse the full report Lidocaine Transdermal Patch Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/lidocaine-transdermal-patch-market

Hospital pharmacy is currently ruling the distribution channel segment in the lidocaine transdermal patch market. The rising prevalence of osteoarthritis causing severe joint pains determines the market growth. Different strengths of lidocaine transdermal patch are dispensed by hospital pharmacists according to the degree of pain intensity and kind of joint pain. Retail pharmacies are garnering huge popularity as a sales channel among consumers worldwide. Flourishing generic medicines market in the developing regions further propel its market growth.

North America is currently leading the geography segment for the lidocaine transdermal patch market. The growing incidence of osteoporosis in the geriatric population causing throbbing joint pain primarily drives the market growth in the region. According to the latest information provided by the Center for Disease Control and Prevention (CDC), approximately 20.4 % population in the United States are suffering from chronic joint pain. Additionally, rising public health awareness pertaining to neuropathic pain and its treatment drives the lidocaine transdermal patch market growth in the region. Europe is placed 2nd in the regional segment due to the significant increase in the number of adults suffering from a shingles infection. As per the statistics provided by the European Commission report, the prevalence rate associated with Herpes Zoster in Europe is 2.5 per 1000 people. The Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period. The constant rise in the injuries associated with sports and athletic activities and flourishing over the counter analgesics market together with determining the lidocaine transdermal patch market in the region.

Pharmaceutical manufacturers actively engaged in the production of Lidocaine Transdermal Patch are Endo International, Plc., Mylan N.V., Teva Pharmaceutical Industries, Ltd., Hisamitsu Pharmaceuticals Co., Inc., Sorrento Therapeutics, Inc., Galen Limited, Seqirus Pty Ltd., ACTAVIS LABS UT INC, CERAMISPHERE and Aetna, Inc.

Key Market Movements:

  • Rising prevalence of shingles infection among the adult population worldwide
  • Significant increase in the number of musculoskeletal disorders causing throbbing joint pains will further accentuate the market growth
  • Technological advancement in the transdermal drug delivery system to provide local anesthetic effect will further propel the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Electrosurgical Cutting Forceps Market is expected to grow at a CAGR of 6.0% from 2020 to 2027

The primary purpose of electrosurgical devices is caused to prevent the bleeding by causing the coagulation of tissue at the site of surgery with the help of either Monopolar or bipolar forceps. Technological advancement in the electrochemical devices and increasing demand for minimally invasive surgical procedures drive the electrosurgical cutting forceps market growth.

In the present situation, the Monopolar forceps are dominating the types segment for the electrosurgical cutting forceps market. The major factors contributing to its market dominance are its applicability in surgical procedures requiring a high degree of tissue desiccation, vaporization and coagulation, and fulguration. Bipolar forceps have gained tremendous demand in the last decade owing to its ability to perform laparoscopic surgical procedures worldwide. Furthermore the ability to coagulate tissue in a fluid environment, and the flow of current being limited to the surgical site ultimately results in the prevention of tissue burns and damages.

Browse the full report Electrosurgical Cutting Forceps Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 report at https://www.atlanticmarketresearch.com/electrosurgical-cutting-forceps-market

Hospitals and clinics are currently representing the largest end-user market for the electrosurgical cutting forceps. Significant rise in the number of outpatient admissions to undergo the surgical procedure as the only viable treatment option for chronic diseases. Huge funding by healthcare agencies worldwide to provide technological advanced electrosurgical devices to hospitals and clinics worldwide. Ambulatory surgical centers are gaining huge traction owing to its ability to drastically reduce the healthcare cost burden of ailing patients and a significant rise in the number of inpatient population opting minimally invasive surgical procedures throughout the globe.

North America is presently spearheading the geography segment for the electrosurgical cutting forceps market. As per the research findings brought forward by the U.S. Department for Health & Human Services in 2018, approximately 129 million outpatient surgeries were performed in the United States. The chief contributing factors such as increasing demand for non-invasive surgical procedures and the presence of key players such as Aesculap, Inc., Elite Medical, CONMED Corporation, Stryker, etc. further promote a positive impetus to the electrosurgical cutting forceps market growth in the region. In Europe, the market growth is defined by the proactive role adopted by the European Medical Agency (EMA) for the early clearance of electrosurgical devices. Western Europe has been pioneering in the manufacturing of invasive and noninvasive surgical devices for centuries and is anticipated to continue the trend during the forecast period. The Asia Pacific is expected to register comfortable growth in the near future owing to the significant rise in medical tourism. The constant rise in the ambulatory surgical centers to address emergency situations in the remote areas further propels the market growth in the region.

Medical device manufacturers engaged in the production of electrosurgical devices are Aesculap, Inc., Erbe Elektromedizin GmbH, Elite Medical, Medtronic, Plc., Ethicon, Inc., Bovie Medical, CONMED Corporation, Bissinger Medizintechnik GmbH, Stryker and BOWA-electronic GmbH & Co. KG.

Market key Takeaways:

  • Significant increase in the number of surgical procedures performed as the only treatment option for chronic diseases
  • Technological advancement in the development of Monopolar and bipolar forceps minimizing tissue burns and damages
  • Increasing demand for minimally invasive surgical procedures and constant rise in the ambulatory surgical centers together drive the electrosurgical cutting forceps market

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Wound Closure Strips Market Is Expected To Grow At A CAGR Of 7.3% From 2019 To 2027

World Health Organization (WHO), has recommended physicians to cover acute and chronic wounds as open tissue injuries are susceptible to bacterial injuries. Looming threat of surgical site infection and superbug infection in hospitals increase the demand for wound closure strips throughout the globe. Zipline wound closure strips and micro anchors wound closure strips are gaining prominence among surgeons worldwide. Strategic collaboration between pharmaceutical companies to increase their product portfolio for wound closure devices. The major hurdle faced by this market is by the stiff competition imposed by the demand for surgical staples and sutures for acute and chronic wounds.

Elastic wound closure strips are spearheading the types segment. The chief factors responsible for its market growth are its flexibility to stretch according to different body movement without compromising on the comfort level. It is the most ideal wound closure strip for contoured body surface which is susceptible to swelling and edema. The reinforced wound closure strips find a huge application for covering wounds obtained due to deep lacerations and surgical incisions.

Browse the full report Wound Closure Strips Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/wound-closure-strips-market

Hospitals & clinics are holding the largest market share for the end-user segment in the wound closure strips market. Significant rise in the number of surgeries performed and constant rise in the inpatient admission to a medical emergency and surgery centers due to fatal accidents drive the market growth for the hospital & clinics. Household demand for wound closure strips are gaining tremendous traction on account of the injuries caused due to laceration and cuts obtained while performing daily household chores. The ease and convenience in the application of wound closure strips further bolster its demand for the protection of wounds associated with household injuries.

North America held the largest market in 2018, in the geography segment for the wound closure strips market. The major contributing factors pertaining to its market growth are a significant rise in the number of surgeries performed and the looming threat associated with surgical site infection. The market growth of Europe is dependent on parameters such as the presence of key players such as 3M Company, Cardinal Health, Inc., Smith & Nephew, Plc. etc. The proactive role adopted by the European Medical Agency (EMA) for the early clearance of wound closure devices further accentuates the market growth in the European Union region. Asia Pacific will be showcasing affirmative growth during the forecast period owing to the significant rise in fatal accidents associated with road and highway vehicle collision and occupational hazards.

Pharmaceutical companies engaged in the manufacturing of wound closure strips are Cardinal Health, Inc., DeRoyal Industries, Inc., DermaRite Industries, LLC., Dynarex Corporation, 3M Company, Hill-Rom Holdings, Inc., Medline Industries, Inc., McKesson Corporation, Integra LifeSciences Holdings Corporation, and Smith & Nephew, Plc.

Market Key Takeaways:

  • Significant rise in the number of surgical procedures performed and surgical site infection worldwide
  • Strategic collaboration between pharmaceutical companies to increase their product portfolio pertaining to wound closure devices
  • Rising prevalence of fatal accidents related to roadside vehicle collision and occupational hazards

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Audiometric Screening Equipment Market Is Expected to Grow At A CAGR of 6.6% from 2020 to 2027

According to the statistics provided by the World Health Organization (WHO), by 2050 it is estimated that 1 in 10 people will be suffering from hearing disability worldwide. Technological advancement in the audiometric screening equipment will drive the market growth in the near future.

Conductive hearing loss is dominating the largest market share in the indication segment for audiometric screening equipment. It occurs when the sound is blocked either in the outer ear canal or the middle ear. The chief causative factors associated with the disease etiology are patients suffering from otosclerosis and cerumen impaction. Recurrent episodes of tinnitus and infection of Eustachian fluid infection may result in the development of conductive hearing loss. Sensorineural hearing loss will be registering rampant market growth in the indication segment for the audiometric screening equipment market. The key parameters responsible for the disease prognosis are listening to loud noise or explosion, blow to the head, aging, etc.

Browse the full report Audiometric Screening Equipment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/audiometric-screening-equipment-market

Hospitals are currently leading the end-user segment for audiometric screening equipment market growth. Rising prevalence of otitis media infection and rising noise population causing trauma to eardrums has resulted in frequent patients visits to the hospital for initial screening and treatment for ear diseases. Specialty clinics are expected to record steady market growth during the forecast period owing to the significant increase in the congenital hearing disability in children and proactive government initiatives to establish specialty clinics to reduce the healthcare burden associated with government-sponsored hospitals.

North America is reigning the geography segment for the audiometric screening equipment market. According to the latest information provided by the American Speech-Language-Hearing Association (ASHA), the prevalence rate of hearing loss is 2 to 3 per 1000 children in the United States. Furthermore, clinical research studies have elucidated that approximately 15% of the United States population is suffering from hearing loss. Domicile of key players such as MAICO Diagnostics, Vivosonic, Inc., Natus Medical Incorporated., etc. further propels the market growth in the region. Europe is considered as the second-largest regional segment owing to the rising prevalence of presbycusis. As per the latest research citings presented by the World Health Organization approximately 33% of the geriatric population above 65 years of age suffer from some hearing defect in the Asia Pacific region. A significant increase in the otitis media infection eventually causing injury to the eardrums will further accentuate the market growth in the region.

Medical device manufacturers actively engaged in the production of audiometric screening equipment are MAICO Diagnostics, OTODYNAMICS LTD., Intelligent Hearing Systems, Natus Medical Incorporated, Vivosonic, Inc., INVENTIS SRL., AUDITDATA A/S, Benson Medical Instruments Co., 3M Company and Demant A/S.

Key Market Movements:

  • Rising prevalence of otosclerosis and presbycusis in the adult population worldwide
  • Growing incidence of congenital hearing defects in children throughout the globe
  • Proactive initiatives adopted by government healthcare agencies to invest huge funds in procuring audiometric screening equipment to diagnose and treat ear defects

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Corticosteroid Nasal Sprays Market Is Expected To Grow At A CAGR Of 4.5% From 2020 To 2027

The latest information provided by the American Academy of Allergy Asthma and Immunology (AAAAI), it is estimated that 10-30 percent of the global population is suffering from allergic rhinitis. Rising prevalence of chronic rhinosinusitis and seasonal flu together will drive the corticosteroid nasal sprays market. The major hurdle faced by this market is the intense competition imposed by the antihistaminic nasal sprays for providing symptomatic relief of the upper respiratory tract infections.

Budesonide is presently spearheading the drug class segment for corticosteroid nasal sprays market. It is used as first-line therapy for attenuating the inflammation associated with seasonal allergic rhinitis and is crucial in providing symptomatic relief such as itching sneezing and runny nose. Fluticasone is will showcase magnificent market growth in the near future owing to its therapeutic efficacy in the treatment of nasal polyps and significantly reduces the inflammation associated with chronic rhinosinusitis. Triamcinolone is frequently prescribed by pediatricians for treating seasonal flu and allergic rhinitis in children’s belonging to the age group of 2 to 5 years owing to its therapeutic efficacy and safety.

Browse the full report Corticosteroid Nasal Sprays Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/corticosteroid-nasal-sprays-market

Hospital pharmacy is leading the distribution channel segment for corticosteroid nasal sprays market. The chief contributing factor catering to its positive market growth is a significant increase in the number of patients visiting hospital pharmacies with a prescription for the treatment of seasonal allergic rhinitis. The retail pharmacy has gained tremendous traction in the last decade on account of the availability of corticosteroid nasal sprays as the over the counter products.

North America is dominating the geography segment for corticosteroid nasal sprays market. According to the latest research citings brought forward by the National Ambulatory Medical Care Survey (NAMCS), approximately 35 million United States citizens are reported to be suffering from rhinosinusitis per year. Additionally, the favorable reimbursement scenario for the use of prescribed corticosteroid nasal sprays further propels its market growth in the region. Europe is at the 2nd place on account of the rising prevalence of allergic rhinitis across all age groups in the region. As per the statistics provided by the European Academy of Allergy and Clinical Immunology approximately 100 million Europeans suffer from allergic rhinitis infection. Asia Pacific is keen to register magnificent market growth in the near future on account of the tropical weather of SE Asian countries that is suitable for the disease progression of seasonal flu infection. The existence of a developed generic market accentuates the corticosteroid nasal sprays market in the Asia Pacific.

Pharmaceutical companies engaged in the production of corticosteroid nasal sprays are AstraZeneca AB, Chattem, Inc., GlaxoSmithkline, Plc., OptiNose US, Inc., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Sandoz, Inc., Perrigo Company, Plc., and Pfizer, Inc.

Market Key Takeaways:

  • Rising prevalence of allergic rhinitis and chronic rhinosinusitis throughout the globe
  • Affordable reimbursement scenario for the corticosteroid nasal sprays prescribed for treating seasonal and allergic reactions of the upper respiratory tracts
  • Presence of generic market in developing countries and availability as over the country products in developed countries together drive corticosteroid nasal sprays market

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Glaucoma Drugs Market is expected to grow at a CAGR of 4.0% from 2020 to 2027

According to the latest statistics provided by the International Agency for the Prevention of Blindness (IAPB) by 2020, approximately 3.2 million people will be reported blind due to glaucoma. Researchers are working on developing novel drug development for the treatment of glaucoma.

Prostaglandins are spearheading the drug class segment for the glaucoma drug market. They are currently used as a first-line therapy due to positive patient compliance as only a single dose is required daily, it acts by relaxing muscles of the eyes interior structure in order to promote fluid drainage and reduce eye pressure. Beta-blockers are used in combination with prostaglandins for the treatment of glaucoma, it is helpful in the treatment of glaucoma by reducing the fluid production in the eye. Carbonic anhydrase inhibitors and alpha-adrenergic agonists are used in combination with other drugs that are employed when it is eminent to decrease the rate of aqueous humor production in glaucoma patients. The recent launch of novel drugs employed in glaucoma management such as Rhopressa and Vyzulta which have superior therapeutic efficacy and safety in comparison to traditional drugs will be the fastest-growing drug class.

Browse the full report Glaucoma Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/glaucoma-drugs-market

Hospital pharmacy is dominating the distribution channel segment for the glaucoma drugs market. Precise compounding of glaucoma drugs especially in combination therapy is important to prevent drug-related side effects, hospital pharmacist is vital in dispensing glaucoma drugs according to the prescription. The retail pharmacy will be the fastest-growing distribution channel segment during the forecast period on account of its ability to provide generic versions of glaucoma drugs at attractive prices.

North America is leading the geography segment for the glaucoma drugs market. A significant increase in the number of glaucoma cases primarily drives the glaucoma drug market in the region. According to the recent research findings presented by BrightFocus Foundation glaucoma is the leading cause of blindness among Hispanics and African Americans. Furthermore, the existence of well-developed healthcare infrastructure and the presence of major players such as Allergan, Plc., Alcon, Bausch & Lomb, Novartis AG, etc. buttress the market growth in the region. Europe is considered as the second-largest regional market due to the supportive regulatory environment provided by the European Medical Agency (EMA) for the sale and distribution of glaucoma drugs and affordable reimbursement scenario for glaucoma drugs in the region. Asia Pacific is set to be the fastest-growing regional market for glaucoma drugs chiefly due to the rising prevalence of glaucoma in the elderly population and the presence of flourishing generic drugs market.

Pharmaceutical companies actively engaged in the manufacturing of glaucoma drugs are Allergan, Plc, Alcon, Novartis AG., Merck KGaA, Pfizer, Inc., Aerie Pharmaceuticals, Inc., Bausch + Lomb, Inotek Pharmaceuticals, Teva Pharmaceutical Industries, Ltd., and Santen Pharmaceutical Co., Ltd.

Market Key Takeaways:

  • Significant increase in the number of people suffering from glaucoma worldwide
  • Recent launch of novel drugs for management of glaucoma such as Rhopressa and Vyzulta will further accentuate the market growth
  • Affordable reimbursement scenario for the glaucoma drugs used in the treatment propels the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Medical Mechanical Ventilators Market Is Expected to Grow At A CAGR of 3.2% from 2020 to 2027

The present scenario of COVID-19 infection which severely damages the respiratory system of the infected person has led to the tremendous demand for mechanical ventilators throughout the globe. Increasing consumption of tobacco at an early age, rising air pollution, and a significant increase in surgical procedures for the treatment of chronic diseases together consolidate the medical mechanical ventilators market growth.

Intensive care are representing the largest market share in the product segment for the mechanical ventilators market. A significant rise in pandemic RNA viral diseases causing damage to the respiratory functions of ailing patients increases the demand for intensive care mechanical ventilators. Increasing growth observes in specialty clinics will further fortify market growth. Neonatal mechanical ventilators will record marvelous market growth during the forecast period on account of the rising prevalence of Down syndrome and spina bifida in the neonates worldwide.

Hospitals & clinics are currently dominating the end-user segment for the medical mechanical ventilators market. Rising prevalence of chronic bronchitis due to the constant rise in smoking and air pollution primarily drives the market growth. A significant increase in the neonates born with congenital deficiency and preterm births will further bolster the market growth. Ambulatory surgical centers are expected to showcase impressive market growth in the near future primarily due to its ability to reach the site of accidents and immediately provide medical aid to victims to maintain their homeostasis.

Browse the full report Medical Mechanical Ventilators Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/medical-mechanical-ventilators-market

North America is presently leading the geography segment for the medical mechanical ventilators market. The rising prevalence of cystic fibrosis in an aging population with chronic smoking history primarily drives the market growth in the region. According to the latest research citings presented by the American Lung Association (ALA), the chronic obstructive pulmonary disease is the 4th largest cause of death in the United States. Domicile of major players such as GE Healthcare, Koninklijke Philips N.V., Smiths Medical, etc. will further bolster the market growth in the region. Europe is the second-largest regional segment on account of the early CE certification provided by the European Medical Agency (EMA), for its high rate of adoption and installation in the government-sponsored hospitals. The Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period on account of a constant rise in the medical tourism industry and proactive role adopted by the government in providing huge funds to hospitals to purchase large quantities of mechanical ventilators for their intensive care units.

Medical device manufacturers actively engaged in the production of medical mechanical ventilators are GE Healthcare, Koninklijke Philips N.V., Dragerwerk AG & Co. KGaA., Medtronic, plc., Getinge AB, Smiths Medical, ResMed, Inc., Teleflex Incorporated, Becton Dickinson & Company, and Carl Reiner GmbH.

Key Market Movements:

  • Rising prevalence of chronic lung disease worldwide
  • Increasing growth in the point of care centers will further increase the demand for mechanical ventilators
  • Pandemic outbreaks cause the need for mechanical ventilators to stabilize patient health conditions

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Ketotifen Fumarate Market is expected to grow at a CAGR of 2.9% from 2020 to 2027

As per the latest information brought forward by the World Health Organization (WHO) each year approximately 250,000 deaths related to asthma are reported worldwide. Ketotifen fumarate is ketotifen is a selective, non-competitive H1 receptor antagonist and mast cell stabilizer which is frequently used for the treatment of various kinds of allergic reactions.

As per the latest statistics brought forward by the Global Asthma Report 2018, asthma causes the death of 1000 people every day and approximately affects 339 million people worldwide. Currently Atopic asthma is dominating the indication segment for ketotifen fumarate market growth. Pediatricians use it more frequently as a prophylactic agent in children for the treatment of atopic asthma as it is a basophil and mast cell stabilizer and a potent H1 receptor antagonist. It is anticipated that the allergic seasonal conjunctivitis is set to register excellent market growth owing to the constant rise in the air and water pollution and allergens which are the primary causative agent for the clinical manifestation of allergic seasonal conjunctivitis. The availability of different ophthalmic solutions as generic and OTC products further buttress its market growth.

Browse the full report Ketotifen Fumarate Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/ketotifen-fumarate-market

Hospital pharmacy is presently ruling the distribution channel segment for the ketotifen fumarate market. The capability to perform precise compounding of different dosage and formulation of ketotifen fumarate to treat various allergic reactions overcomes the possibility of adverse drug reaction owing to overdose toxicity. Retail pharmacy is on a rise in the developing regions on account of the establishment of burgeoning generic market and availability of ketotifen fumarate formulations as over the counter products (OTC) products.

North America is presently the highest shareholder in the geography segment for the ketotifen fumarate market. The major contributing factors responsible for its magnificent market growth are rising prevalence of allergic reactions, as per the research citings brought forward by the American Academy of Allergy Asthma & Immunology (AAAAI) approximately 50 million Americans are suffering from some form of allergic disease. Domicile of key players such as Allergan, Plc., Apotex, Corp., Novartis Pharma AG, etc further consolidates its market growth in the region. The market growth in Europe is primarily determined by the rising prevalence of allergic asthma, according to the statistics provided by the European Respiratory Society (ERS) approximately 30 million adults and children in the European region are suffering from allergic asthma. Asia Pacific is keen to register faster market growth during the forecast period on account of the presence of a huge generic market and rising incidence of allergic seasonal conjunctivitis due to dust, pollutants, pollen, and animal dander.

Pharmaceutical companies actively engaged in the manufacturing of the ketotifen fumarate market are Bausch & Lomb, Allergan, Plc., Apotex Corp., Novartis Pharma AG., Alcon Laboratories, Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Thea Laboratories, Cadila Healthcare, and Mylan Labs Ltd.

Market Key Takeaways:

  • Rising prevalence of allergic reactions on account of increasing pollution, allergens, dust and animal dander
  • Availability of different formulations of ketotifen fumarate as generic versions and OTC products
  • Supportive regulatory environment for the sale and distribution of ketotifen fumarate formulations across the globe

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Levobupivacaine Market is expected to grow at a CAGR of 3.5% from 2020 to 2027

Levobupivacaine is a long-acting local anesthetic agent belonging to the amido amine group, it is basically an S-enantiomer of bupivacaine drug. It has become popular among anesthesiologists worldwide owing to its less cardiotoxicity and motor blockade. It was primarily developed due to the reported incidents of seizures and cardiac arrests experienced due to the use of intravenous injection of bupivacaine. Significant rise in surgeries performed and increasing demand for post-operative pain management drive the levobupivacaine market growth.

Epidural anesthesia is currently representing the largest market share in the levobupivacaine market. The major features which are responsible for its market dominance are a significant rise in the labor pain experience during livebirths. It is the most preferred local anesthetic for epidural anesthesia during live births to obtain pain relief to the mothers experiencing labor pain. The amount of anesthetic agent delivered can be adjusted in epidural anesthesia depending upon the intensity of pain experienced by the mother during labor. Spinal anesthesia are is required for surgeries that are performed below the umbilicus such as orthopedic surgery of the hip, pelvis, knee, and vascular surgeries of the legs. Peripheral nerve blocks are anticipated to gain huge traction during the forecast period owing to the significant rise in the number of fatal accidents inflicting grievous injuries to victims and increasing demand for postoperative pain management.

Browse the full report Levobupivacaine Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/levobupivacaine-market

Hospital pharmacy is currently spearheading the end-user segment for the levobupivacaine market. The inherent features such as immaculate compounding of local anesthetic drugs and the ability to cater to the medical needs of patients 24/7 primarily determine its market growth. Retail pharmacy is constantly increasing in numbers in the developing regions on account of the existence of a huge generic market and provisions of medicines at a discounted rate.

North America is dominating the geography segment for levobupivacaine market. A significant rise in the number of surgeries performed and effective implementation of guidelines pertaining to pain management therapy primarily determines the levobupivacaine market growth. Additionally, the favorable reimbursement scenario associated with the use of levobupivacaine during surgical procedures further accentuates its market growth in the region. Europe is in the 2nd place in the geography segment for levobupivacaine market. The constant rise in the dental and cosmetic surgeries performed increases the demand for levobupivacaine as a local anesthetic agent in the European Union region. Asia Pacific is set to embark on impressive market growth in the near future on account of the growing medical tourism industry and developing healthcare infrastructure.

Pharmaceutical companies actively engaged in the manufacturing of levobupivacaine are AbbVie, Inc., Fresenius Kabi, Altan Pharma, AstraZeneca, Plc., Maruishi Pharmaceutical Co., Ltd., Hengrui Therapeutics, Inc., Cristália, Pharos Ltd., Yangzhou Tianhe Pharmaceutical and Ropsohn Therapeutics.

Market Key Takeaways:

  • Constantly increasing number of surgical procedures and labor pain experienced with livebirths worldwide
  • Excellent pharmacodynamic and pharmacokinetic drug profile renders it safe and efficacious in comparison to ropivacaine and bupivacaine
  • Affordable reimbursement scenario associated with the use of levobupivacaine in surgical procedures

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Flecainide Market is expected to grow at a CAGR of 3.2% from 2020 to 2027

Flecainide is classified as a class 1 antiarrhythmic drug which received USFDA approval in 1985 for the treatment of atrial fibrillation and ventricular tachycardia. It causes the inhibition of the sodium and potassium ion channels in the heart causing an increase in the heart threshold for depolarization and correcting arrhythmias. It is available in doses of 50,100 and 150mg tablets for the treatment of different severity of cardiac arrhythmias.

Supraventricular tachycardia is presently leading the indication segment for the flecainide market. The chief causative agents for its clinical manifestations are preexisting heart failure complications and congenital heart disease. Paroxysmal supraventricular is most commonly found in the women and older adults population throughout the globe. Atrial Fibrillation is caused by factors such as hypertension, coronary artery disease and lung diseases. As per the World Health Organization (WHO), in 2017 approximately 3.046 million new cases were reported to be suffering from atrial fibrillation. Wolff-Parkinson-White Syndrome is anticipated to register rampant market growth during the forecast period on account of a constant rise in the newborn suffering with Ebstein anomaly which is manifested by the structural defect of the tricuspid valve which allows the blood to flow from the right atrium to right ventricles.

Browse the full report Flecainide Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/flecainide-market

Hospital pharmacy is spearheading the end-user segment for the flecainide market. The major features which attributes to its superior market growth are the availability of skilled pharmacist to compound different doses of flecainide for patients suffering from different severity of cardiac arrhythmias. Retail pharmacy is gaining huge prominence in the developing regions owing to the ever-increasing generic market and capability to provide medical needs of cardiac patients residing in the remote locations.

North America is representing the largest market in the geography segment for the flecainide market. As per the latest research citings presented by the Center for Disease Control and Prevention (CDC), in 2017 atrial fibrillation was responsible for the deaths of 166,793 U.S. citizens. Furthermore effective implementation of treatment guidelines pertaining to cardiovascular complications and affordable reimbursement scenario for flecainide used in the treatment of heart diseases further buttresses the flecainide market growth in the region. Europe is in the 2nd position in the geography segment on account of the constantly growing generic market for flecainide and recommendation of European Medical Agency (EMA) to use flecainide as the first-line therapy for paroxysmal supraventricular tachycardia in elderly patients. Asia Pacific is set to witness lucrative market growth on account of developing healthcare infrastructure and a significant rise in the medical tourism industry.

Pharmaceutical companies actively engaged in the manufacturing of flecainide are Mylan Labs Ltd., Aurobindo Pharma, Amneal Pharmaceuticals, LLC., Sun Pharmaceutical Industries Ltd., Apotex, Inc., Bausch Health, AvKARE, Inc., Eisai Co., Ltd., ANI Pharmaceuticals and InCarda Therapeutics, Inc.

Market Key Takeaways:

  • The constant rise in the number of patients suffering from supraventricular tachycardia and atrial fibrillation
  • Effective implementation of treatment guidelines pertaining to cardiovascular complications to drive flecainide market
  • Affordable reimbursement scenario and the existence of well-developed generic market to further propel the flecainide market

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Medical Isolation Eye Masks Market is expected to grow at a CAGR of 8.3% from 2020 to 2027

The primary objective of medical isolation eye masks or shields is the protection of the mucous membranes of the eye region from sprays, splashes, and spatter of body fluids, it is used together with other personal protective equipment.

Surgical procedures are representing the largest market share in the application segment for the medical isolation eye masks market. According to the latest information provided by the World Health Organization (WHO), the global surgical rate is estimated to be 4,469 operations per 100,000 people per year. Increasing demand for surgical interventions throughout the globe as a treatment option for lifestyle disorders such as cardiovascular disease, gastrointestinal disorders, pulmonary complications, etc. Screening go biological samples is estimated to showcase excellent market growth in the near future owing to the rising public health awareness resulting in early screening and diagnosis of infectious diseases. Constantly growing life sciences segment diligently working to build immunity against fatal infectious diseases increases the demand for medical isolation eye masks.

Browse the full report Medical Isolation Eye Masks Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/medical-isolation-eye-masks-market

Hospitals & clinics are leading the end-user segment for the medical isolation eye masks market. The chief attribute contributing to its positive market growth is the significant rise in chronic diseases requiring surgical intervention as a treatment option. Ambulatory surgical centers have gained tremendous traction in the last 2 decades owing to a significant increase in outpatient visits due to its ability to reduce the healthcare cost burden. It is crucial in catering medical assistance to patients residing in remote locations.

North America is dominating the geography segment for the medical isolation eye masks market. The constant rise in the number of patients suffering from lifestyle disorders requiring surgical intervention as a treatment option. Recent information provided by the National Hospital Ambulatory Medical Care Survey (NHAMCS), annually,28.6 million U.S. citizens visit to perform surgical procedures to both hospitals and ASC combined. The presence of key players Medline Industries, Inc., McKesson Corporation, Halyard Health, Prestige Ameritech, etc. further accentuates the market growth in the region. Europe is the second-largest regional market for the medical isolation eye masks market. A strategic partnership between government healthcare agencies and pharmaceutical firms in the development of novel vaccines and drugs to curb the mortality rate associated with fatal infectious disease. Asia Pacific is anticipated to register comfortable market growth during the forecast period on account of rising public health awareness resulting in early screening of virulent infections and flourishing life sciences industry.

Medical devices companies actively engaged in providing medicines for the treatment of Medical Isolation Eye Masks are Medline Industries, Inc., McKesson Corporation, Halyard Health, S2S GLOBAL, 3M Healthcare, Yanming Global, AVI Global Plast., Alpha Pro Tech, Ltd., Prestige Ameritech, and Sanax Protective Products.

Market Key Takeaways:

  • Significant increase in the number of surgical procedures performed worldwide
  • Increasing public health awareness resulting in early screening of fatal infectious diseases
  • Supportive role adopted by the global healthcare regulatory agencies in  promoting the sale and distribution of medical isolation eye masks market

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Protective Surgical Gowns Market Is Expected to Grow At A CAGR of 6.2% from 2020 to 2027

Protective surgical gowns are classified as a Class II medical device which requires a 510(k) premarket notification by the USFDA. The manufactures are engaged in the production of protective surgical gowns on the basis of its use as per the AAMI classification of 1-4 risk levels.

Disposable gowns are representing the largest market share in the type segment for the protective surgical gowns market. The ergonomic features associated with disposable protective surgical gowns are cost-effectiveness and high safety assurance, there is no extra cost incurred for bleaching, disinfecting and conditioning, etc. Manufacturers are producing disposable protective surgical gowns that are made from hypoallergenic material which provides maximum safety from biohazard exposure. The looming threat of hospital-acquired infections (HAI’s) and the growing incidence of microbial resistance further propel market growth. Reusable surgical gowns are expected to showcase appreciable market growth in the near future owing to its increasing demand in the pharmaceutical industry and academic research institutes worldwide. Medical grade fabric is being utilized in the manufacturing of reusable protective surgical gloves which has high fluid resistance, provides maximum protection form biohazard exposure, and stain free. Regular autoclaving and washing with disinfectant renders it clean and safe for recurrent use.

Browse the full report Protective Surgical Gowns Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/protective-surgical-gowns-market

Hospitals & clinics are currently leading the end-user segment for the protective surgical grounds market. Spreading of viral infections worldwide at an alarming rate creates the requirement of immediate screening of susceptible patients at government-sponsored hospitals and clinics. A constant rise in the surgical procedures opted by the patients for the treatment of chronic diseases worldwide further accentuates the market growth. Ambulatory surgical centers are anticipated to register rampant market growth on account of its ability to provide emergency medical services to injured people on highways and remote locations.

North America is presently dominating the geography segment for the protective surgical gowns market. A significant increase in the research and development activities in the life sciences segment primarily drives the market growth in the region. The existence of developed healthcare infrastructure further accentuates the protective surgical gown’s market growth. The presence of key players such as Halyard Health, 3M Company, Medline Industries, Inc., Cardinal Health, etc. will further bolster the market growth in the region. Europe is the second-largest regional segment owing to the significant increase in the number of surgical procedures performed in the region. The Asia Pacific is anticipated to be the fastest market growth during the forecast period on account of the developing healthcare infrastructure and lucrative market opportunities for western giants to establish retail outlets and subsidiaries in the Asia Pacific.

Surgical products manufacturers actively engaged in the production of protective surgical gowns are Mölnlycke Health Care AB, Halyard Health (Owens & Minor), 3M Company, Medline Industries, Inc., Vygon S.A., Cardinal Health, Lohmann & Rauscher GmbH & Co. KG., Ahlstrom-Munksjö, PRIMED Medical Products, Inc., and Priontex (PTY) LTD.

Key Market Movements:

  • Significant increase in the number of surgical procedures performed worldwide
  • Spreading of infectious diseases across the globe at an alarming rate creates the need for effective screening and treatment thereby increasing the demand for protective surgical gowns
  • Continuous growth in the research and development activities in the life sciences sector to provide excellent healthcare facilities further accentuate the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Forecast Market Outlook Market Report Market Reports

Global Double Chamber Prefilled Syringes Market Is Expected to Grow at a CAGR of 9.1% from 2020 to 2027

As per the latest research citings presented by the World Health Organization (WHO) by 2020, approximately 57% of the global burden of the disease will be associated with non-communicable diseases. It further caters to the burgeoning requirement of biomolecules and lyophilized drugs for its treatment which increases the demand for double chamber prefilled syringes.

Glass is presently leading the material segment for a double chamber prefilled syringes market. The ergonomic features associated with glass which increase its popularity as the most desirable material for the manufacturing of double chamber prefilled syringes are transparency, non-reactivity with chemical moieties, antileaching properties, etc. Furthermore, it prevents oxidation, hydrolysis, and reduction reaction of the drug compounds present in the prefilled syringe, however, the fragile nature is the biggest obstacle faced by the glass as a product material. Plastics are expected to register marvelous market growth during the forecast period owing to the technological advancement in the development of cyclic olefin copolymers. Polymers exhibit minimal drug absorption, offer compatibility with a wide range of drug molecules, additionally improved resilience to pH range and reduced surface reactivity further increases its demand as a material for the manufacturing of double chamber prefilled syringes worldwide.

Browse the full report Double Chamber Prefilled Syringes Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/double-chamber-prefilled-syringes-market

Hospital pharmacy is currently spearheading the distribution channel segment for a double chamber prefilled syringes market. Injectable has a rapid onset of action and fatal outcomes in cases of overdose hence, it becomes imperative for the hospital pharmacist to diligently compound the injectable in accordance with the physician’s prescription. Retail pharmacies are gaining huge attraction in the developing world on account of the huge discount provided by the retailers on the purchase of essential medicines and the ability to serve patients in remote locations.

North America is presently dominating the geography segment for a double chamber prefilled syringes market. Increasing demand for biologics and lyophilized drugs for the treatment of chronic diseases primarily drives the double chamber prefilled syringes market growth in the region. As per the latest research citings presented by the National Health Council (NHC), approximately 40% of the American population suffers from a chronic disease that requires immediate medical intervention. Additionally, the domicile of major players such as Pfizer, Inc., AbbVie, Inc., Otsuka America Pharmaceutical, Inc., etc. further accentuates the market growth in the region. Europe is placed in second place in the regional segment primarily due to a supportive regulatory environment provided by the European Medical Agency (EMA) for the double chamber prefilled syringes market growth. The Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period primarily due to the developing healthcare infrastructure. Additionally, it serves as a potential opportunity for western players to establish subsidiaries and retail outlets in the Asia Pacific region.

Pharmaceutical manufacturers actively engaged in the production of double chamber prefilled syringes are NIPRO PHARMA CORPORATION, Pfizer, Inc., Credence MedSystems, Inc., Ypsomed AG., Vetter Pharma International GmbH., Otsuka America Pharmaceutical, Inc., MAEDA INDUSTRY Co., Ltd., AbbVie, Inc., Gerresheimer Bünde GmbH and Baxter AG.

Market Key Takeaways:

  • Rising prevalence of chronic and rare diseases worldwide
  • Technological advancement in the development of double chamber prefilled syringes further accentuate its market growth
  • Increasing demand for biologics and lyophilized chemical moieties to be injected as medicines for the treatment of rare diseases

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Sivelestat Sodium Market Is Expected To Grow At A CAGR Of 4.6% From 2020 To 2027

Sivelestat sodium is a competitive inhibitor of neutrophil elastase, it was used as a drug candidate during the severe acute respiratory syndrome (SARS) epidemic which occurred in China in 2003. Many pharmaceutical companies did not proceed with the clinical trials back then as the SARS epidemic was over. Recently it came to cognizance after the National Medical Products Administration of China (NMPA), has given approval for the use of sivelestat sodium in the treatment of COVID-19 infection.

Acute lung injury is reigning the treatment segment for the sivelestat sodium market. The key attributes responsible for the disease prognosis of acute respiratory distress syndrome are aspiration, pneumonia, and extrapulmonary sepsis, etc. The clinical manifestations associated with the disease are refractory hypoxemia, accumulation of pulmonary edema which decreases the lung’s capacity in eliminating carbon dioxide. It is still the most undertreated medical condition which has a mortality rate of 40%. Pediatric cardiopulmonary bypass surgery is anticipated to be the fastest-growing treatment segment on account of the ability of sivelestat sodium in reducing the perioperative inflammatory response and drastically reduces the duration of mechanical ventilation.

Browse the full report Sivelestat Sodium Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/sivelestat-sodium-market

Hospitals and clinics are spearheading the end-user segment for the sivelestat sodium market. Patients throughout the globe suffering from acute respiratory distress syndrome are immediately hospitalized in the critical care units of hospitals and clinics to stabilize the medical condition by mechanical ventilation. Ambulatory surgical centers will be registering lucrative market growth during the forecast period owing to its ability to serve patients residing in remote locations.

Asia Pacific is dominating the geography segment for the sivelestat sodium market. Rising prevalence of acute respiratory distress syndrome (ARDS), the major countries contributing to its supreme epidemiological count is Japan, China South Korea, etc. As per recent statistics provided by the World Health Organization (WHO), the annual incidence rate of acute respiratory distress syndrome in the Asia Pacific region is 15.19 per 100,000 people. Additionally, the presence of major players such as Ono Pharmaceutical Co., Ltd, Teva Takeda Yakuhin Ltd, and Shanghai Huilun Jiangsu Pharmaceutical Co. Ltd, etc. fortify the market growth in the region. Europe is the second-largest market on account of the rising prevalence of aspiration induced acute lung injury in the European Union region. Proactive role adopted by the European Medical Agency (EMA) to conduct clinical trial investigation pertaining to the therapeutic efficacy and safety of sivelestat sodium in curbing the High mortality rate associated with COVID -19 infection. North America will be the fastest-growing regional segment in the near future owing to the rising prevalence of acute lung failure. According to the recent facts provided by the American Journal of Respiratory and Critical Care Medicine annually in the United States 190,600 cases of acute respiratory distress syndrome are reported.

Pharmaceutical companies actively engaged in the production of sivelestat sodium are Merck KGaA., Enzo Life Sciences, Inc., Ono Pharmaceutical Co., Ltd., Teva Takeda Yakuhin Ltd., Tocris Bioscience, Cayman Chemical, Shanghai Huilun Jiangsu Pharmaceutical Co. Ltd., R&D Systems, Inc., Toronto Research Chemicals and Abcam, plc.

Market Key Takeaways:

  • Rising prevalence of acute respiratory distress syndrome worldwide
  • A constant increase in the patients suffering from acute lung injury associated with aspiration, pneumonia and pulmonary sepsis
  • Proactive role adopted by global healthcare agencies in conducting clinical trial studies to investigate the therapeutic efficacy and safety of sivelestat sodium in the treatment of COVID-19 infection

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Hydroxychloroquine Sulfate Tablets Market is expected to grow at a CAGR of 4.7% from 2020 to 2027

Hydroxychloroquine sulfate tablets are enlisted on the World Health Organization (WHO) list of essential medicines. As an antimalarial drug its mechanism of action comprises increasing the lysosomal pH of the antigen-presenting cells. In the treatment of autoimmune diseases such as rheumatoid arthritis and lupus erythematosus it has been reported to block the toll-like receptor signals to reduce the inflammation. Currently it is under investigation for its therapeutic efficacy for the treatment of COVID-19 infection.

Hydroxychloroquine sulfate tablets are still considered as a first-line drug therapy for geographical regions where chloroquine resistance is not reported. The posology associated with malaria treatment is 400mg weekly starting 2 weeks before exposure and is continued for 4 weeks after leaving the endemic area. It is successfully employed as a DMARD medicine for the treatment of rheumatoid arthritis with the dosage of 400-600 mg/day in the BID, used in combination with corticosteroids or salicylates for better results. The drug also finds application in the treatment of lupus erythematosus in which the drug posology is 200mg single dose per day.

Browse the full report Hydrochloroquine Sulfate Tablets Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/hydroxychloroquine-sulfate-tablets-market

Hospital pharmacies are spearheading the end-user segment for hydroxychloroquine sulfate tablets market. It favors the capability of dispensing a different dose of hydroxychloroquine for different age group patients to prevent overdose toxicity which is fatal. Retail pharmacy is quite popular in the developing regions owing to the presence of a huge generic market for hydroxychloroquine sulfate tablets which are sold at cheap price and it caters to the medical needs of patients residing in remote locations.

Middle East and Africa are currently leading the geography segment for hydroxychloroquine sulfate tablets market. The rising prevalence of malarial infection in the sub-Saharan region responsible for 93% of all known mortality associated with malaria causes tremendous demand for hydroxychloroquine which is still used as a first-line drug therapy. The region receives free medical aid from regulatory bodies such as WHO, Red Cross, etc. for the treatment of malarial infection. Latin America represents the second-largest regional market on account of the presence of a large rain forest area which is a teeming growing for malarial infection. Asia Pacific is keen to register impressive market growth during the forecast period on account of the presence of tropical and subtropical climate in SE Asian countries which favors the spread of malaria-infected mosquitos, furthermore, the cheap generic market further propels the hydroxychloroquine sulfate tablets market growth. In developed regions such as North America and Europe it is used for the treatment of autoimmune disease.

Pharmaceutical companies actively engaged in the manufacturing of hydroxychloroquine sulfate tablets are Mylan Labs Ltd., Teva Pharmaceutical Industries Ltd., Sanofi SA., Sandoz, IPCA Laboratories Ltd., Amneal Pharmaceuticals, Inc., Cadila Healthcare, Bristol Laboratories Ltd., AvKARE, Inc. and Covis Pharmaceutcials, Inc.

Market Key Takeaways:

  • Rising prevalence of malaria in the tropical and subtropical regions of the world
  • Therapeutic efficacy of the hydroxychloroquine sulfate in autoimmune diseases such as rheumatoid arthritis and lupus erythematosus further propels its market growth
  • Affordable reimbursement scenario for the hydroxychloroquine sulfate tablets used as a medication

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Umbilical Cord Clamps Market Is Expected To Grow At A CAGR Of 5.2% From 2020 To 2027

Umbilical cord is a gynecological instrument which is used for clamping the umbilical cord after the live birth in order to separate the newborn from the mother’s placenta. Earlier the waiting period before clamping was considered as 1 minute but current guidelines pertaining to obstetrics and gynecology consider 3 to 5 minutes necessary to ensure optimum blood iron level in the newborn.

Stainless steel umbilical cord clamps are frequently used as they are safe to reuse after they have been rendered sterile by autoclaving with other gynecological devices. They are considered as a green alternative to plastic and polymer-based clamps and hence does not require a cutting tool. Polymer-based umbilical cord clamps will be the largest and fastest-growing product segment during the forecast period. Inherent features such as non-toxic, sterile, and pyrogen-free polymers used in manufacturing clamps which are intended for single-purpose thereby drastically reducing the risk of cross-contamination. It ensures protection against accidental reopening, provides excellent angle movement for the clamps which is gaining huge popularity among gynecologists as it is relatively safe to use due to the presence of grooves and notches on the clippings surface which prevents slipping of the umbilical cord and reduces injury.

Browse the full report Umbilical Cord Clamps Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/umbilical-cord-clamps-market

Hospitals are currently spearheading the end-user segment for the umbilical cord clamps market. It is the first point of contact for middle and low-income households seeking midwifery medical services. Clinics are gaining tremendous market growth owing to its ability to provide obstetrics and gynecological services to people inhabiting in remote locations.

North America is currently dominating the geography segment for the umbilical cord clamps market. The primary factor which determines its market dominance is the significant rise in the number of live births. According to the latest statistics brought forward by the American College of Obstetricians and Gynecology (ACOG) approximately 3.79 million live birth took place in the United States in 2018. Domicile of key manufacturers such as Medline Industries, Inc., Angiplast, Ardo, Medgyn Products Inc., further propel the market growth in the region. Europe is in the 2ndposition in the geography segment for the umbilical cord clamps market. A significant rise in the delayed cord clamping after live births to ensure optimum blood iron level in the newborn primarily determines the market growth in the region. It is expected that the Asia Pacific is keen to register comfortable market growth in the near future on account of huge funding issued by government healthcare agencies for securing women and child health and welfare.

Medical device manufacturers actively manufacturing umbilical cord clamps are Angiplast, Ardo, Medline Industries, Inc., Medgyn Products, Inc., Mediscope International Limited, Surtex Instruments Limited, Denticon Surgical Instruments, Besmed Health Business Corp., Birth Supplies Canada, and R.I.MOS. Srl.

Market Key Takeaways:

  • Increasing number of live births worldwide and rising trend of nurturing new family among adults
  • Significant rise in the demand for polymer-based umbilical cord clamps which are disposable and reduces risk of cross-contamination
  • Effective implementation of guidelines pertaining to obstetrics and gynecology worldwide increasing demand for umbilical cord clamps market

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Household Handheld Intraoral Endoscopes Market Is Expected to Grow at a CAGR of 9.4% from 2020 to 2027

According to the latest research citings provided by the World Health Organization (WHO), approximately 3.5 billion people worldwide are suffering from oral diseases. Intraoral endoscopes were developed in the early 1990s in order to replace the mirrors used by dental and maxillofacial surgeons to achieve an excellent view of the oral cavity and its complications and save the images in the patient’s health record for future reference.

Universal serial bus (USB) is spearheading the product type segment for household handheld intraoral endoscopes market. The primary purpose of USB is to provide connection sot electronic gadgets without the need for docking stations and unnecessary use of cables which adds to the exorbitant maintenance cost in the long run. It provides multitasking features from time to time such as ensuring optimum power supply, integration with imaging software to gain a high-resolution image of the oral cavity, etc. Wi-Fi is anticipated to register nimble market growth during the forecast period on account of the technological advancement in Wi-Fi which provides seamless integration with different versions of imaging software. Furthermore, ergonomic features offered by Wi-Fi such as less interference, a faster and excellent range of connectivity with android, and other ios applications will propel its market growth.

Browse the full report Household Handheld Intraoral Endoscopes Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/household-handheld-intraoral-endoscope-market

The supermarket is presently leading the distribution channel segment for household handheld intraoral endoscopes market. The majority of the consumers opt for a one-stop shopping experience on weekends and hence the supermarket serves as a lucrative platform to exhibit intraoral endoscopes of vast diversity at affordable prices. E-commerce is expected to record comfortable market growth in the near future on account of technological advancement in smartphones and increasing internet penetration to bolster its market growth. E-commerce offers discount coupons on festive seasons which attracts huge consumer base across the globe.

North America is currently dominating the geography segment for household handheld intraoral endoscopes market. A significant increase in gingivitis primarily drives market growth in the region. As per the latest statistics provided by the Center for Disease Control and Prevention (CDC), in the U.S. approximately 16.9% and 31.6% dental caries are untreated in the children and adult population respectively. Furthermore, the domicile of major players such as Carestream Health, SOTA Imaging, Lensiora, ProDent, etc. further bolsters the market growth in the region. Europe is considered as the second-largest regional segment owing to the strategic collaboration between research academia and medical device manufacturers engaged in the technological development of the household handheld intraoral endoscopes in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period on account of increasing dental complications in people habituated to chewing of betel nuts and tobacco products. The competitive market created by the western giants to the local players will further drive the market growth in the region.

Medical device manufacturers actively engaged in the production of household handheld intraoral endoscopes are Apexel, ProDent, Lensiora, DARYOU Dental, KaVo Dental, SOTA Imaging, Carestream Health, DÜRR DENTAL SE, Dongguan Magenta Technology Co., Ltd., and Shenzhen MingNanHuitai Tech.

Market Key Takeaways:

  • Rising prevalence of oral diseases and dental cavities worldwide
  • Technological advancement in the household handheld intraoral endoscopes will accentuate the market growth
  • The supportive regulatory environment provided by the global healthcare agencies to the distribution of household handheld intraoral endoscopes market

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Outlook Market Report Market Reports

Global Bio pharma Buffer Market Is Expected To Grow At A CAGR of 7.2% From 2020 to 2027

Biopharma buffers are used to resist change in the pH and ionic concentration of biochemical process under clinical investigation, buffers basically comprise of acid and base conjugates. Henderson-Hasselbalch equation is critical in determining the pH of the buffer solutions such as acetates, phosphates, carbonates, organic buffers, etc.

Phosphate buffers are presently dominating the type segment for the biopharma buffer market on account of increasing demand from the life science industry and academic research institutes. The major factors responsible for its huge popularity among researchers is its pH, osmolarity, and ionic concentration similar to the human bodily fluids. It is used as the diluent, rinse containers containing cells, reference spectrum to measure protein adsorption on ellipsometry. Acetate buffers are widely employed in molecular biology especially in the purification and precipitation of nucleic acids. Organic buffers will be showcasing magnificent market growth on account of increasing demand for novel drug development such as vaccines, immunotherapy, biologics, etc.

Browse the full report Bio Pharma Buffer Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/bio-pharma-buffer-market

The biopharmaceutical industry is currently leading the end-user segment for the biopharma buffer market. Significant rise in the spread of virulent diseases such as ebola, COVID-19, swine flu, etc. creates the burgeoning requirement for the development of vaccines and novel drugs to prevent the spread and reduce the mortality rate associate with the viral infections. Academia and research institutes worldwide are keen to register rampant market growth owing to the strategic collaboration between pharmaceutical companies to promote breakthrough research and technology to serve mankind. Huge monetary funds provided by governmental healthcare agencies to establish academic research institutes.

North America is currently representing the largest market share in the geography segment for the biopharma buffer market. The key attributes associated with its market dominance are proactive role adopted by healthcare agencies to promote research and development activities for the treatment of infectious and lifestyle disorders in the region. The existence of well-developed healthcare infrastructure and constantly growing biopharmaceutical segments together drive the biopharma buffer market in the region. Europe is in the 2nd position in the regional market for the biopharma buffer market. Increasing demand for the discovery of novel vaccines and immunotherapy to treat infectious and autoimmune disease further propel the biopharma buffer market growth in the region. The Asia Pacific is anticipated to register comfortable market growth during the forecast period on account of developing healthcare infrastructure and flourishing drug formulation and development market.

Biopharmaceutical companies actively engaged in the manufacturing of biopharma buffer are Merck KGaA.,Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Lonza, Becton Dickinson and Company, Promega Corporation, GE Healthcare, ANGUS Chemical Company, Takara Bio, Inc., and VWR International, LLC.

Market Key Takeaways:

  • Significant increase in the drug development activities across the life science industry
  • Rising prevalence of infectious disease creates a burgeoning requirement of novel drug discovery and vaccine development to curb its fatality
  • The constant rise in the academic research institutes worldwide to promote breakthrough research and technology to cater to the medical needs of mankind

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Neonatal Enteral Feeding Devices Market Is Expected to Grow at a CAGR of 6.3% from 2020 to 2027

Medical device manufactures are using materials for neonatal enteral feeding which exhibits resilience to a wide range of pH, excellent tensile strength, gentle to body tissue and does not favor the growth of any bacteria over its surface.

Feeding pumps are reigning the product type segment for neonatal infants enteral feeding devices market. The feeding of human milk is very critical in neonates who are ill and very frail to be breastfed. The continuous feeding of milk might lose fat and protein content and hence the feeding pumps are necessary to avoid nutrition depletion by providing rotating pole clamps, flow rate accuracy, interlocking connectors to prevent the accidental pull apart, and bolus protection. Feeding tubes will be registering marvelous market growth during the forecast period on account of the increasing number of neonates born with very low birth weight worldwide. Polyurethane tubes are preferred over PVC and silicone tubes due to its ergonomic features such as soft at body temperature, relatively thin wall which does not collapse when suction is applied and has a large interior diameter and small exterior diameter.

Browse the full report Neonatal Enteral Feeding Devices Market  – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/neonatal-infants-enteral-feeding-devices-market

Hospitals & clinics are presently leading the end-user segment for neonatal infants enteral feeding devices market. In the developed countries the neonates are born in the government-funded hospital and clinics which have the provision of neonatal intensive care units to provide medical assistance to sick neonates. Ambulatory surgical centers will be registering rampant market growth in the near future chiefly due to its ability to provide neonatal intensive care services for neonates born in remote locations.

North America is currently spearheading the geography segment for neonatal infants enteral feeding devices market growth. A constant rise in the number of neonates being exposed to nosocomial infection determines the market growth in the region. According to the latest recent findings provided by the Center for Disease Control and Prevention (CDC), the deaths per 100,000 live births in the U.S. are 566.2 each year. Additionally, the presence of major players such as Cardinal Health, Inc., Becton Dickinson, and Company, Atlanta Biomedical Corporation, Moog, Inc., etc. further accentuate the market growth in the region. Europe is the second-largest regional market, on account of the supportive regulatory environment provided by the European Medical Agency for the sale and distribution of neonatal enteral feeding devices. The Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period. A significant increase in the number of preterm births reported each year drives the neonatal enteral feeding devices market.

Medical device manufacturers actively engaged in the production of neonatal enteral feeding devices are Cardinal Health, Inc., Vygon SA., Becton Dickinson and Company., Atlanta Biomedical Corporation., Moog, Inc., DEGANIA SILICONE, LTD., Avanos Medical Devices., Canafusion., GBUK Group Ltd., and CAIR LGL.

Key Market Movements:

  • Significant increase in the number of preterm births and neonates born with very low body weights worldwide
  • A constant rise in the neonates exposed to nosocomial infection accentuates the enteral feeding devices market growth
  • Technological advancement in the neonatal enteral feeding devices will further propel the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Outlook Market Report Market Reports

Global Favipiravir Market is expected to grow at a CAGR of 4.8% from 2020 to 2027

Favipiravir functions as a prodrug which undergoes ribosylation and phosphorylation to get converted into the active favipiravir-RTP which inhibits RNA dependent RNA polymerase to prevent the transcription and replication of the viral genome.

Influenza is currently representing the largest market share in the treatment segment for favipiravir market. As per the latest statistics provided by the World Health Organization (WHO), approximately 650,000 deaths are reported with influenza infection and it is estimated to cause severe illness in 3 to 5 million people worldwide. Countries having cool temperate climates are teeming grounds for influenza B viral infection whereas, tropical climate supports the spread of influenza A viral infection. Lack of self-hygiene and poor vaccination programs are the primary factors for the spread of influenza infection in developing countries. Ebola is a deadly viral infection affecting humans and non-human primates, the four species which are known for its infections in humans are Sudan, Zaire, Bundibugyo, and Taï of which the Zaire species is the most lethal. The mortality rate associated with Ebola is ranging from 22% to 88% and the onset of the disease is sudden and intense, transmitted rapidly in human beings by contact with bodily fluids. Currently, the entire globe is under the threat of COVID-19 infection, China being the epicenter, huge mortality rate and lack of vaccine increases the demand for favipiravir as a promising drug for the treatment of COVID-19 infection in the near future.

Browse the full report Favipiravir Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/favipiravir-market

Hospital pharmacy is leading the distribution channel segment for the favipiravir market. It is imperative to take antiviral drugs under medical supervision as non-adherence to prescription might result in toxicity and severe drug-related side effects. Hospital pharmacist is critical in adjusting the dose regimen in accordance with a doctor’s prescription. Retail pharmacy gaining huge market traction in the developing regions on account of a significant increase in viral infections in slum areas and the ability to cater to medicinal requirements of patients residing in far-flung remote areas.

The Asia Pacific is presently dominating the geography segment for the favipiravir market. The chief attribute responsible for its market dominance is the significant rise in the incidence rate of influenza A. viral infection in the South East Asian region. The recurrent occurrence of seasonal influenza is due to factors such as the tropical climate, high humidity, and monsoon climate. Additionally, the domicile of major players such as Fujifilm Toyama Chemical Co., Ltd, Zhejiang Hisun Pharmaceutical Co., Ltd., Cipla Limited, Beximco Pharmaceuticals Limited, etc further propels the market growth in the region. Europe is in the Northern Hemisphere with a cool temperate climate which is teeming grounds for the rampant spread of influenza B. viral infection during the winter season. Central Africa has the most reported cases of Ebola infection in the world which increases the demand for the favipiravir market in the region. North America is anticipated to register magnificent market growth in the near future owing to the proactive role adopted by the healthcare agencies in conducting clinical trials to study the therapeutic efficacy and safety for the treatment of people suffering from COVID-19 infection.

Biopharmaceutical companies actively engaged in the manufacturing of favipiravir are Fujifilm Toyama Chemical Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd., Cipla Limited., Lasa Supergenerics Limited., ChemRar Group., Beximco Pharmaceuticals Limited., Beacon Pharmaceuticals., Clinigen Group and Medivector, Inc.

Market Key Takeaways:

  • Significant increase in the number of RNA virus infection such as influenza, ebola, etc. throughout the globe
  • Positive results obtained from clinical trial studies pertaining to the therapeutic efficacy and safety of favipiravir for the treatment of COVID-19
  • The supportive regulatory environment provided by the global healthcare agencies for adopting favipiravir in the treatment of COVID-19

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Albendazole Market Is Expected to Grow at a CAGR of 3.6% from 2020 to 2027

Albendazole is a potent anthelmintic that is used for the treatment of parasitic worm infestation occurring in both the children and the adult population. It needs to be taken under medical supervision in order to prevent severe drug-related adverse events such as headache, nausea, vomiting, abdominal pains, etc.

Currently, the soil-transmitted helminths infection is reigning the clinical application segment for the albendazole market. According to the latest research citings presented by the Center for Disease Control and Prevention (CDC), approximately 2 billion people throughout the globe are suffering from soil-transmitted helminths infection. The different types of soil-transmitted helminths infection occurring worldwide are Ascaris, whipworm, and hookworm, which usually occur in the countries favoring tropical climate. Schistosomiasis will be registering excellent market growth in the near future owing to the key factor such as a significant increase in water population in developing countries due to rapid urbanization. It is also called bilharzia, usually found in the contaminated waters, the most common infections caused in human beings are due to S. japonicum, S. haematobium and S. mansoni etc. According to the latest research citings provided by the World Health Organization (WHO), approximately 290.8 million people worldwide received treatment for schistosomiasis in 2018.

Browse the full report Albendazole Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/albendazole-market

Hospital pharmacy is presently leading the distribution channel segment for the albendazole market. The drug posology for albendazole varies for children and adult, hence it becomes imperative for accurate drug compounding by the hospital pharmacist to prevent the occurrence of any side effects due to drug overdose. Retail pharmacy is anticipated to be the fastest-growing distribution channel segment on account of the existence of a well-developed generic drug market and the ability to provide cheap medicines to patients residing in remote locations.

Asia Pacific is presently dominating the geography segment for the albendazole market. Significant increase in the number of children and women suffering from schistosomiasis infection primarily drives the albendazole market growth in the region. The moist and humid climate present in the south Asian countries favors the spread of neglected tropical diseases. Presence of major players in the region such as Cadila Healthcare Limited, Cipla Limited., GlaxoSmithKline, Plc. Dr. Reddys Laboratories Ltd. etc further propel the albendazole market growth in the region. Latin America is in the second position in the regional segment for the albendazole market. The rising prevalence of genital schistosomiasis infection in the women population determines the albendazole market growth in the region. North America is expected to record rampant market growth during the forecast period. The supportive regulatory environment provided by the USFDA and favorable reimbursement scenario together drive the albendazole market growth in the region.

Pharmaceutical manufacturers actively engaged in the production of albendazole are Cadila Healthcare Limited, Actavis Pharma, Inc., Cipla Limited, GlaxoSmithKline, Plc. Genfar S.A., Dr. Reddys Laboratories Ltd., Beximco Pharmaceuticals Ltd., Unison Laboratories Co Ltd, MEDLEY GENERICOS, and Mankind Pharma.

Market Key Takeaways:

  • Rising prevalence of soli-transmitted helminths infection in tropical countries
  • Significant increase in the number of children and women suffering from schistosomiasis infection worldwide
  • Effective implementation of treatment guidelines pertaining to helminths infection will further accentuate the albendazole market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Ear Bandage Market is expected to grow at a CAGR of 5.0% from 2020 to 2027

Ear bandages are manufactured with the intention to serve a dual purpose which is complete wound closure and subsequent wound healing. The parameters which determine its medical utility are the high retention time, waterproofing, and capability to cover the entire lacerated area of the ear. According to the World Health Organization (WHO), annually more than 50 million people throughout the world suffer from motor vehicle accidents eventually suffering from ear, nose, and cranial laceration. Increasing human-pet adoption will further increase the market demand for the ear bandages.

In the present scenario, one-sided ear bandages are leading the product segment for the ear bandages market. It is the bandage of the first choice for domestic accidents, ornamental ear piercing which often results in an ear infection. The positive ergonomic features associated with the ear bandages such as latex-free material, flexible design to cover complete wound area, and high retention time of the bandage adhesives determine the one-sided ear bandages market growth. Double-sided ear bandages will register sturdy market growth during the forecast period on account of its importance in otoplasty surgical procedures, ear lacerations obtained due to contact sports, and frequent roadside accidents.

Browse the full report Ear Bandage Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/ear-bandages-market

The human application segment is spearheading the ear bandages market. Rising prevalence of roadside accidents, frequent domestic accidents resulting in severe ear laceration increases the demand for ear bandages market. Growing inclination towards contact sports such as boxing and martial arts further increase the demand for ear bandages to tend human ear wounds and lacerations. Animal application segment will register rampant market growth in the near future owing to the increasing pet adoption in developed countries and a significant rise in animal cruelty in the developing regions determines the ear bandages application for tending animal ear wounds and lacerations.

North America is currently holding the largest market share in the geography segment for the ear bandage market. As per the research citings brought forward by the Center for Disease Control and Prevention (CDC), 1 in 7 people in the United States do not wear a seat belt while driving and often result in suffering from severe facial trauma and ear laceration. The presence of emergency medical services further propels the ear bandages market in the region. In Europe, the rising prevalence of household facial accidents and ornamental ear-piercing consolidates the ear bandages market in the region. The Asia Pacific is anticipated to register comfortable market growth owing to the flourishing otoplasty market. An increasing number of cases pertaining to domestic violence further bolsters the ear bandages market growth in the Asia Pacific region.

Pharmaceutical companies actively engaged in the manufacturing of ear bandages are NIPPON EIZAI, SPIGGLE & THEIS Medizintechnik GmbH, Bettering International, Robinson Healthcare, First Aid Bandage Company, Changqing, PREVIS, Phoenix Design Solutions LLC, Pikdare S.r.l. and Lanyuan Healthcare.

Market Key Takeaways:

  • Increasing cases of roadside accidents resulting in eat laceration and facial trauma
  • Technological advancement in the manufacturing of ear bandages ensuring optimum wound closure and prevention of infection
  • The supportive regulatory environment provided by healthcare agencies facilitates its early adoption for wound treatment

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Metronidazole Market is expected to grow at a CAGR of 2.5% from 2020 to 2027

Metronidazole belongs to the nitroimidazole class of antibiotics which is used for the treatment of giardiasis, trichomoniasis, amoebiasis, and other parasitic infections. After the administration of metronidazole, it enters the cells by passive diffusion, ferredoxin reduces it to nitro radicals which selectively blocks the nucleic acid synthesis of microorganisms. Bacterial vaginosis is dominating the treatment segment for the metronidazole market. As per the statistics provided by the World Health Organization (WHO), approximately 84% of the women population suffering from bacterial vaginosis do not show any early symptoms. Major causative agents are sexually transmitted diseases, such as syphilis, gonorrhea, AIDS, chlamydia, herpes simplex, etc. Rosacea is estimated to register excellent market growth during the forecast period owing to the constant rise of rosacea in the Caucasian population worldwide. According to the research citings presented by the European Society for Dermatological Research (ESDR), approximately 400 million people worldwide are suffering from rosacea. Intermittent exposure to sunburn and extreme cold weather causes the disease prognosis of rosacea which is further aggravated by the consumption of tobacco and alcohol. Browse the full report Metronidazole Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/metronidazole-market Hospital pharmacy is reigning the distribution channel segment for the metronidazole market. Accuratedispensingof metronidazole is essential to avoid any drug-related side effects. Hospital pharmacist ensures precise compounding of metronidazole drug formulation in consonance with the physicians prescription. Retail pharmacy is gaining huge demand in developing countries in order to cater to the medicinal needs of a huge population base and availability of generic drugs at attractive prices. North America is spearheading market share in the geography segment for the metronidazole market. Rising prevalence of bacterial vaginosis in women population aged 14 to 49 primarily drives the metronidazole market growth in the region. As per the latest statistics provided by the Center for Disease Control and Prevention (CDC), approximately 29.2% of women population in the United States are suffering from bacterial vaginosis. Affordable reimbursement scenario for different drug formulation of metronidazole accentuates its market growth in the region. Europe represents the 2nd largest market in the regional segment for the metronidazole market. According to the latest research information brought forward by the European Commission the prevalence rate of rosacea is ranging from 9 to 22%, it is highly prevalent in Celtic and German people and has a high incidence rate in the female population in comparison to male. Asia Pacific is going to register magnificent market growth during the forecast period on account of the rising prevalence of gastrointestinal parasitic infection across all age groups and the existence of a well-developed generic drug market in the region. Pharmaceutical companies actively engaged in the manufacturing of metronidazole drug formulation arePfizer, Inc., Lupin Ltd., Auro Pharma, Inc., Viona Pharmaceuticals, Inc., Unichem Pharmaceuticals, Inc., Baxter Healthcare Corporation, Fresenius Kabi AG, Sandoz, Inc., Galderma S.A., and Teva Pharmaceutical Industries Ltd. Market Key Takeaways:
  • Constant rise in the bacterial and parasitic infection worldwide
  • Constant rise in the generic drug market in the developing regions accentuates its market growth
  • Affordable reimbursement scenario for the different metronidazole drug formulation employed in the treatment of bacterial vaginosis, rosacea, amoebiasis, etc.
About Atlantic Market Research Atlantic Market Research is the largest provider of market research and consulting services. Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth. Contact: Mr. Trevor Wilson Atlantic Market Research 911 Central Ave #268 Albany, NY 12206, USA Website: https://www.atlanticmarketresearch.com Email: [email protected]
Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Manidipine Hydrochloride Market Is Expected to Grow at a CAGR of 3.5% from 2020 to 2027

Manidipine hydrochloride causes vasodilation in the kidney region and an increase in natriuresis to produce its antihypertensive effect by reducing the blood volume. Manidipine significantly binds and then slowly dissociates from the T and L type voltage-dependent calcium channels which are present in the smooth muscle of the peripheral vasculature thereby blocking the uptake of extracellular calcium and prevents vasoconstriction.

Moderate hypertension is presently spearheading the clinical application segment for the manidipine hydrochloride market. According to the latest statistics provided by the World Health Organization (WHO), each year hypertension is accountable for 12.8% of the total deaths occurring worldwide. Furthermore, it is estimated that half of the cases suffering from moderate hypertension are subjected to suffer from severe hypertension if accurate first-line therapy is not prescribed by the physicians. Renal protection in type 2 diabetes is anticipated to be registered with sturdy market growth during the forecast period. In patients suffering from preexisting comorbidities such as diabetes and hypertension, there is an 80% chance of developing end-stage kidney disease in the latter part of life.

Browse the full report Manidipine Hydrochloride Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/manidipine-hydrochloride-market

Monotherapy is dominating the treatment regimen segment for the manidipine hydrochloride market. Significant rise in the number of patients suffering from mild to moderate hypertension worldwide primarily drives its market growth. Cardiologist worldwide recommends a dose of 10-20mg once daily for patients suffering from mild to moderate hypertension. Combination therapy has gained prominence in the last 2 decades due to the effective implementation of treatment guidelines pertaining to hypertension management. Delapril 30mg/manidipine 10mg is prescribed for its ability to manage renal complications in type diabetic patients with hypertension.

Europe is presently representing the largest market share in the regional segment for the manidipine hydrochloride market. A constant increase in young adults suffering from moderate hypertension due to increasing consumption of alcohol, tobacco & stressful lifestyle. According to the latest statistics presented by the European Heart Network (EHN), approximately 1.8 million people die annually in the European Union region associated with cardiovascular complications. The presence of well-developed healthcare infrastructure and affordable reimbursement scenario for manidipine hydrochloride drug formulation together drive the market growth in the region. The USFDA has not recommended the use of manidipine hydrochloride in North America. It is expected that the future Asia Pacific will be the fastest-growing regional segment for the manidipine hydrochloride market. A constant rise in geriatric population suffering from end-stage kidney disease & hypertension, and lucrative market opportunities for western giants to establish subsidiaries further accentuate the market growth in the Asia Pacific region.

Pharmaceutical manufacturers actively engaged in the production of manidipine hydrochloride are Chiesi Farmaceutici s.p.a., Takeda Italia SpA, KOSEI PHARMA, Sandoz España (Sandoz Farmacéutica, S.A.), Choseido Pharmaceutical Co., Ltd., Bennett SA, Mylan Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd.

Market Key Takeaways:

  • A constant rise in the number of young adult patients reporting with moderate hypertension worldwide
  • Significant rise in elderly patients suffering from renal complication with preexisting comorbidities such as type 2 diabetes and hypertension
  • Effective implementation in the treatment guidelines pertaining to hypertension management to further accentuate the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global High Definition Breast Tomosynthesis Market is expected to grow at a CAGR of 13.5% from 2020 to 2027

Breast tissues attain different morphology at different stages of life primarily influenced by the hormonal levels and environmental factors affecting the human body. High definition tomosynthesis is an up-gradation to the earlier versions of digital breast tomosynthesis which is useful in achieving high-resolution images and videos of breast cancer cells and tissue under investigation. Breast tomosynthesis employs a low radiation dose by employing an x-ray tube that moves like an arc achieving breast images from different angles to create multiple data points that can be reconstructed in different ways for effective diagnosis of breast cancer cases.

2D/3D combination systems are presently leading the product segment for high definition breast tomosynthesis market. The major factor responsible for its technical viability among oncologists is its capability to precisely analyze the calcification and no calcification cases of breast cancer which is relatively difficult to analyze by employing either dimensional system. Standalone 3D systems are very crucial in screening breast cancer owing to its excellent ergonomic features such as increased sensitivity and reduced recalls rendering it to effectively diagnose invasive cancer cases and reduction in false-positive cases.

Browse the full report High Definition Breast Tomosynthesis Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/high-definition-breast-tomosynthesis-market

Hospitals are dominating the end-user segment for the high definition breast tomosynthesis market. The primary health care centers are the first point of contact for patients opting for early screening of breast cancer. Government health agencies are providing huge funds for the establishment of well-equipped devices for performing screening of breast cancer. Diagnostic centers have gained tremendous traction in the last decade on account of the availability of a skilled workforce for the operating of sophisticated breast tomosynthesis devices and precise interpretation of images.

North America is holding the largest market share in the geography segment for high definition breast tomosynthesis market. As per the research citings brought forward by the American Cancer Society (ACS) in 2019 in the United States approximately 268,600 new cases of breast cancer were reported among the women population. Existence of key players such as Hologic, Inc., GE Healthcare, Siemens Healthineers further propel the market growth pertaining to high definition breast tomosynthesis in the region. In Europe the number of breast cancer cases among the female population as diagnosed in 2018 was 562,500 according to the statistics of the European Breast Cancer Coalition. The strategic collaboration between academic research institutes and medical device manufacturers for the development of breast tomosynthesis devices. Asia Pacific is set to register impressive growth during the forecast period owing to the increasing public health awareness related to the benefits of early screening in breast cancer and developing healthcare infrastructure.

Medical device manufacturers pioneering in the production of high definition breast tomosynthesis are Siemens Healthineers, GE Healthcare, Fujifilm Corporation, Hologic, Inc., Agfa-Gevaert, IMS GIOTTO S.p.A., PLANMED OY., Dexela Ltd., Carestream Health and Metaltronica S.p.A.

Market Key Takeaways:

  • Rising prevalence of breast cancer worldwide
  • Technological advancement and up gradation in the breast tomosynthesis devices to achieve high-resolution images
  • Strategic collaboration between academic research institutes and medical device manufactures to develop high definition breast tomosynthesis devices

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Delapril Hydrochloride Market Is Expected to Grow at a CAGR of 2.3% from 2020 to 2027

Delapril hydrochloride is a prodrug that gets converted to active metabolite 5-hydroxy delapril diacid which exerts its antihypertensive activity by preventing the conversion of angiotensin 1 to angiotensin 2, thereby enhancing the excretion of sodium and hence causing an increase in water outflow.

Hypertension is presently spearheading the clinical application segment for the delapril hydrochloride market. As per the latest statistics provided by the World Health Organization (WHO), approximately two-thirds of the global cases of hypertension are occurring in low and middle-income countries. It is considered a serious medical condition that increases the risk of damaging internal organs such as the brain, kidney, heart, lungs, etc. Further research studies convey that 1 in 4 men and 1 in 5 women suffer from hypertension worldwide. Type 2 diabetes with hypertension is anticipated to be the fastest-growing clinical application segment for the delapril hydrochloride market. As per the latest research citings presented by the American Diabetes Association (ADA), the coexistence of type 2 diabetes and hypertension increases 4 fold risk of developing heart stroke and end-stage kidney disease in a later stage of life.

Browse the full report Delapril Hydrochloride Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/delapril-hydrochloride-market

Combination therapy is the largest and fastest segment in the delapril hydrochloride market. Delapril is used in combination with manidipine and indapamide for the effective management of hypertension. Delapril 30 mg /indapamide 2.5 mg is beneficial in hypertensive patients who are at greater risk of suffering from a cerebrovascular stroke in later stages of life. The combination of manidipine 10mg/delapril 30mg is prescribed for managing hypertension in type 2 diabetic patients owing to its renoprotective properties. Monotherapy of delapril is currently used in a few countries in the European countries such as Italy, Spain, and Germany, etc. owing to its ability to reduce the mortality rate associated with hypertension in the geriatric population.

Europe is presently dominating the geography segment for the delapril hydrochloride market. The rising prevalence of hypertension in the younger population in the European Union region primarily drives its market growth. The major causative agents for the occurrence of hypertension are obesity, sedentary lifestyle, unhealthy diet, stress, etc. As per the latest research citings presented by the European Heart Network (EHN) cardiovascular diseases are responsible for 45% of all the deaths in the European region. Affordable reimbursement scenario and favorable regulatory environment provided by the European Medical Agency (EMA), for the manufacturing and sale of delapril hydrochloride further accentuates its market growth in the region. Delapril hydrochloride is not available in North America. Asia Pacific is expected to register rampant market growth during the forecast period. A significant increase in the elderly population type 2 diabetes with hypertension drives the delapril hydrochloride market growth in the region.

Pharmaceutical manufacturers actively engaged in the production of delapril hydrochloride are Chiesi Farmaceutici s.p.a., Promedica Srl, Tokyo Chemical Industry Co., Ltd, Glentham Life Sciences Ltd, LGM Pharma, IWAKI SEIYAKU CO., LTD., Merck KGaA., and MASTER PHARMA Srl.

Key Market Movements:

  • Significant increase in the early onset of hypertension in young adult population worldwide
  • A constant rise in the number of type 2 diabetic patients suffering from hypertension
  • Supportive regulatory environment provided by the global healthcare agencies for the monotherapy and combination therapy of delapril hydrochloride throughout the globe

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Medicinal Mushroom Extracts Market is expected to grow at a CAGR of 9.3% from 2020 to 2027

Medicinal mushrooms are fungal organism which is used as a nutritional supplement and healthy food in daily diet. Rising prevalence of lifestyle disorders and rising public health awareness together drive the medicinal mushroom extracts market growth.

Reishi medicinal mushroom is presently leading the type segment for the medicinal mushroom extract market. It is being used by the royal families since ages for its ability to increase longevity & antiageing properties and hence known as the mushroom of immortality. Reishi comprises ganoderic acid which is critical in reducing high blood pressure and cholesterol levels. Reishi also possesses important properties such as antiviral, antibacterial, etc. and is essential in boosting the immune system. The Chaga medicinal mushroom will be the fastest-growing type segment during the forecast period on account of its immunomodulation properties by stimulating the production of antibodies to fight the invading virus and pathogens. Diligent research has led to the conclusion that it is beneficial in treating autoimmune diseases such as psoriasis, rheumatoid arthritis, etc.

Browse the full report Medicinal Mushroom Extracts Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/medicinal-mushroom-extracts-market

Immunity enhancers are spearheading the clinical application segment for the medicinal mushroom extracts market. As per the World Bank report in 2017, the global healthcare burden associated with communicable disease and nutritional deficiency was 28% due to low immunity in infected patients. Medicinal mushrooms are vital in enhancing immunity by stimulating lymphocytes, cytokines, macrophages, etc. Anticancer clinical application will be showcasing comfortable market growth in the near future owing to the rising prevalence of cancer worldwide. Pharmacological active compounds such as lectins, schizophyllan, lentinan, active hexose correlated compounds, etc. have proved beneficial in the treatment of various cancers such as breast, cervical, colorectal, skin, etc.

North America is the clear leader in the geography segment for the medicinal mushroom extracts market. The rising prevalence of cancer significantly increases the demand for medicinal mushroom extracts in the North American region. As per the latest information provided by the American Cancer Society (ACS), in 2019 approximately 140,690 new cases of cancer were reported in the United States. Rising public health awareness and increasing inclination for the adoption of medicinal mushroom extracts as a nutraceutical supplement further consolidates the market growth in the region. Europe stood second in the regional segment for the medicinal mushroom extracts market. The constant increase in viral infections on account of compromised immunity determines the medicinal mushroom extracts market growth in the region. Asia Pacific is going to be the fastest-growing regional segment on account of the significant increase in the geriatric population suffering from autoimmune diseases.

Nutraceutical companies actively engaged in the provision of medicinal mushroom extracts areNammex, Amax NutraSource, Inc., Oriveda BV, Bio-Botanica, Inc., Nutra Green Biotechnology Co., Ltd., Yuikiguni Maitake Corp., Xian Yuensun Biological Technology Co., Ltd., Nyishar, Hokkaido Reishi Co. Ltd., and Aloha Medicinals, Inc.

Market Key Takeaways:

  • Constant rise in chronic lifestyle disease worldwide
  • Rising public health awareness and growing inclination pertaining to the adoption of medicinal mushroom extracts as a dietary supplement
  • Systematic scientific verification of active compounds present in the medicinal compounds will further increase the demand for medicinal mushroom extracts in Lifesciences industry

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Hydroxycarbamide Market is expected to grow at a CAGR of 2.2% from 2020 to 2027

According to the latest statistics presented by the World Health Organization (WHO), each year approximately 300,000 infants are born with sickle cell anemia. Sickle cell disease is most commonly encountered in people belonging to the Middle East, Sub Saharan Africa, and South Asia region.

Sickle cell disease is ruling the application segment for the hydroxycarbamide market. As per the research citings provided by the World Health Organization (WHO), approximately 20 to 25 million people worldwide are linked with genetic traits associated with sickle cell disease. It is a genetic disorder in which there are not enough healthy red blood cells to carry oxygen in different parts of the human body. Myeloproliferative diseases will be registering rampant market growth owing to the fast track designation status awarded to hydroxycarbamide for the treatment of rare diseases such as chronic myeloid leukemia and polycythemia Vera etc.

Browse the full report Hydroxycarbamide Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/hydroxycarbamide-market

Hospital pharmacy is reigning the distribution channel segment for the hydroxycarbamide market. Hydroxycarbamide is a potent antineoplastic agent in which accurate compounding according to physicians prescription is essential in order to prevent drug-related adverse events. It needs to be strictly taken under medical supervision owing to its toxic nature. Retail pharmacy is gaining strong grounds in the developing nations on account of its ability to sell different generic versions of hydroxycarbamide at affordable prices.

North America is currently dominating the largest market in the geography segment for the hydroxycarbamide market. The rising prevalence of sickle cell disease chiefly drives the hydroxycarbamide market growth in the region. As per the latest statistics presented by the Center for Disease Control and Prevention (CDC), sickle cell disease affects approximately 100,000 Americans, the incidence rate is 1 in 365 African-American births, and 1 in 16,300 Hispanic-American birth, etc. Affordable reimbursement scenario and the existence of well-developed healthcare infrastructure further bolster the market growth in the region. Europe stands 2nd in the regional segment for the hydroxycarbamide market. The supportive regulatory environment provided by the European Medical Agency (EMA) for the sale and distribution of hydroxycarbamide primarily drives the market growth in the European Union region. Furthermore, the strategic partnership between academic research institute and pharmaceutical companies to validate the therapeutic efficacy of hydroxycarbamide in the treatment of psoriasis further consolidates the market growth in the region. The Asia Pacific will register rampant growth in the regional segment on account of the rising prevalence of cervical cancer in women population and the presence of a well-developed generic drug market in the Asia Pacific region.

Pharmaceutical companies actively engaged in the manufacturing of hydroxycarbamide areBristol Myers Squibb & Company, Teva Pharmaceutical Industries Ltd., Sandoz, Inc., HEXAL AG., Cadila Healthcare, Cipla Limited, AvKARE, Inc., Par Pharmaceutical, Apotex Corporation, and Addmedica.

Market Key Takeaways:

  • Significant increase in the number of patients suffering from sickle cell disease worldwide
  • Increasing research activities conducted in clinical trials investigation to harness the therapeutic efficacy of hydroxycarbamide to treat chronic myeloid leukemia and psoriasis
  • Constant rise in retail pharmacy and well established generic drugs market in the developing regions to propel the hydroxycarbamide market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Fosfomycin Market Is Expected to Grow at a CAGR of 3.2% from 2020 to 2027

Fosfomycin is a broad-spectrum antibiotic having activity against gram-negative and gram-positive bacteria, it exerts its pharmacological activity by causing interference in the production of the bacterial cell wall. It is enlisted in the World Health Organization (WHO), list of essential medicines.

Urinary tract infection is currently reigning the clinical application segment for the fosfomycin market. A significant increase in urban industrialization has led to the establishment of huge slums in the metropolitan cities having poor civic amenities. Residents of slum areas are repeatedly exposed to causative agents such as E.coli and E. faecalis and hence suffer from complicated urinary tract infection with a 50% recurrence in previously affected patients. According to the World Health Organization (WHO), approximately 150 million people worldwide are affected by urinary tract infections each year. Prostatitis is anticipated to be the fastest-growing clinical application segment during the forecast period. A constant rise in a geriatric population having frequent urine leakage in the prostate glands and previous nerve or muscle injury in the lower urinary tract are responsible for the occurrence of prostatitis infection in the adult male population throughout the globe.

Browse the full report Fosfomycin Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/fosfomycin-market

Hospital pharmacy is leading the distribution channel segment for the fosfomycin market. Fosfomycin is a broad-spectrum antibiotic-associated with severe drug-related side effects thus it is necessary for the hospital pharmacist to precisely compound the fosfomycin to negate the occurrence of any adverse events. Retail pharmacy is gaining tremendous demand in developing countries due to the presence of a well-developed generic drug market and the availability of medicines at affordable prices.

North America is presently dominating the geography segment for the fosfomycin market. The rising prevalence of prostatitis in the adult male population primarily drives the fosfomycin market growth in the region. As per the latest research citings provided by the Center for Disease Control and Prevention (CDC), the incidence rate of prostatitis in the male population in the United States is 4.9% per 1000 people each year. Furthermore, the domicile of major players in the region such as Verity Pharmaceuticals, Inc., Abbvie, Jamp Pharma Corporation, etc. further propels the market growth in the region. Europe is the second-largest regional segment for the fosfomycin market. Rising prevalence of healthcare-associated urinary tract infection (HAUTIs) determines the fosfomycin market growth in the region. According to the latest statistics presented by the European Commission report, the prevalence rate of HAUTIs is 19.6% in the region. Asia Pacific is set to be the fastest-growing regional segment for fosfomycin market. A significant increase in water and soil population has led to a constant rise in urinary tract infection in people residing in the slums. Additionally, the presence of a flourishing generic drug market further accentuates the fosfomycin market growth in the Asia Pacific region.

Pharmaceutical manufacturers actively engaged in the production of fosfomycin are Verity Pharmaceuticals, Inc., Allergan, Plc. (Abbvie), Jamp Pharma Corporation, Mayne Pharma Group, Nabriva Therapeutics, Plc., Takeda Teva Pharma Ltd., Sun Pharmaceutical Industries Ltd., The Zambon Group, Infectopharm and Macleods Pharmaceuticals Pvt, Ltd.

Market Key Takeaways:

  • Rising prevalence of urinary tract infection worldwide
  • Significant increase in the number of cases of prostatitis in elderly population throughout the globe
  • Affordable reimbursement scenario for the fosfomycin drug formulation further bolster its market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Global Market Market Forecast Market Outlook Market Report Market Reports

Global Dietary Fiber Nutritional Supplements Market is expected to grow at a CAGR of 12.6% from 2020 to 2027

Nutritional science has undergone tremendous technical development in the last 5 decades eventually resulting in effective extraction from natural sources such as cereals, grains, fruits, and vegetables. Rising prevalence of gastrointestinal disorders, growing inclination for the consumption of unhealthy junk food, and sedentary lifestyle determines the dietary fiber nutritional supplements market growth. Proactive marketing of dietary fibers on social media will further accentuate the dietary fibers market growth in the near future.

The soluble dietary fibers are spearheading the type segment for dietary fiber nutritional supplements market. It is further sub-segmented as pectin, inulin, polydextrose, beta-glucan, etc. It usually forms a viscous gel-like substance when it comes in contact with the digestive fluid. It usually delays the digestion rate thereby reduces the feeling of hunger and food intake and is capable of maintaining a healthy weight. It has the ability to sequester blood cholesterol and is helpful in regulating blood glucose levels. It has been crucial in preventing the disease manifestation of chronic diseases such as cardiovascular disease and type 2 disease. Insoluble dietary fibers are gaining tremendous importance in their ability to maintain healthy gut flora and regulation of a peristaltic activity which is beneficial in treating chronic constipation.

Browse the full report Dietary Fiber Nutritional Supplements Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/dietary-fiber-nutritional-supplements-market

The supermarket is reigning the distribution channel segment in the dietary fiber nutritional supplements market. The chief contributing factors responsible for its market dominance are its inherent features such as lower operation and overhead cost and location in the central place of the city which attracts a huge customer base. It has the ability to display dietary fibers from several manufacturers and endorsed by different brands at competitive prices. E-commerce has gained tremendous traction in the last decade on account of a significant rise in the population using smartphones at the ability to reach a huge customer base with dietary fiber products at attractive discount rates.

North America is dominating the geography segment for the dietary fiber nutritional supplements market. The rising prevalence of the geriatric population suffering from gastrointestinal disorder primarily drives the market growth. Domicile of key players such as Archer Daniels Midland Company, BENEO, Cargill Corporation, DuPont, etc. further fortifies the dietary fiber nutritional supplements market in the region. Europe is in the 2nd place on account of the rising public health awareness regarding the useful application of insoluble fibers in achieving healthy gut microflora and peristaltic activity. The Asia Pacific is expected to register rampant market growth in the near future on account of the flourishing e-commerce segment which is providing a diverse range of dietary fiber products at affordable prices and attractive coupons.

Pharmaceutical companies manufacturing dietary fiber nutritional supplements are Archer Daniels Midland Company, Royal DSM, Citrucel, Robinson Pharma, Inc., BENEO, Cargill Corporation, Tate & Lyle, Plc., Viachem, Meron Group, and DuPont.

Market Key Takeaways:

  • Rising prevalence of gastrointestinal disorders in the elderly population worldwide
  • Increasing public health awareness regarding the useful application of prebiotics in maintaining healthy gut microflora and motility
  • Flourishing e-commerce segment providing a diverse range of dietary fibers at affordable prices and attractive coupons

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]